232 related articles for article (PubMed ID: 17227437)
21. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Venti A; Giordano T; Eder P; Bush AI; Lahiri DK; Greig NH; Rogers JT
Ann N Y Acad Sci; 2004 Dec; 1035():34-48. PubMed ID: 15681799
[TBL] [Abstract][Full Text] [Related]
22. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
[TBL] [Abstract][Full Text] [Related]
23. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Chaston TB; Lovejoy DB; Watts RN; Richardson DR
Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
[TBL] [Abstract][Full Text] [Related]
24. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.
Daws LC; Callaghan PD; Morón JA; Kahlig KM; Shippenberg TS; Javitch JA; Galli A
Biochem Biophys Res Commun; 2002 Feb; 290(5):1545-50. PubMed ID: 11820798
[TBL] [Abstract][Full Text] [Related]
25. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
[TBL] [Abstract][Full Text] [Related]
26. GDNF signaling in embryonic midbrain neurons in vitro.
Consales C; Volpicelli F; Greco D; Leone L; Colucci-D'Amato L; Perrone-Capano C; di Porzio U
Brain Res; 2007 Jul; 1159():28-39. PubMed ID: 17574220
[TBL] [Abstract][Full Text] [Related]
27. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
28. A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking.
Nass R; Hahn MK; Jessen T; McDonald PW; Carvelli L; Blakely RD
J Neurochem; 2005 Aug; 94(3):774-85. PubMed ID: 15992384
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells.
Qian JJ; Cheng YB; Yang YP; Mao CJ; Qin ZH; Li K; Liu CF
Neurosci Lett; 2008 Apr; 435(2):142-6. PubMed ID: 18342443
[TBL] [Abstract][Full Text] [Related]
30. The role of gamma-synuclein in cocaine-induced behaviour in rats.
Boyer F; Dreyer JL
Eur J Neurosci; 2008 Jun; 27(11):2938-51. PubMed ID: 18588534
[TBL] [Abstract][Full Text] [Related]
31. Aging effects on the dopamine transporter expression and compensatory mechanisms.
Cruz-Muros I; Afonso-Oramas D; Abreu P; Pérez-Delgado MM; Rodríguez M; González-Hernández T
Neurobiol Aging; 2009 Jun; 30(6):973-86. PubMed ID: 17976862
[TBL] [Abstract][Full Text] [Related]
32. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
Richardson D; Ponka P; Baker E
Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
[TBL] [Abstract][Full Text] [Related]
33. Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens.
Richards TL; Zahniser NR
J Neurochem; 2009 Mar; 108(6):1575-84. PubMed ID: 19183252
[TBL] [Abstract][Full Text] [Related]
34. Isoflurane induces dopamine transporter trafficking into the cell cytoplasm.
Byas-Smith MG; Li J; Szlam F; Eaton DC; Votaw JR; Denson DD
Synapse; 2004 Aug; 53(2):68-73. PubMed ID: 15170819
[TBL] [Abstract][Full Text] [Related]
35. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
Sakrikar D; Mazei-Robison MS; Mergy MA; Richtand NW; Han Q; Hamilton PJ; Bowton E; Galli A; Veenstra-Vanderweele J; Gill M; Blakely RD
J Neurosci; 2012 Apr; 32(16):5385-97. PubMed ID: 22514303
[TBL] [Abstract][Full Text] [Related]
36. Activity and subcellular trafficking of the sodium-coupled choline transporter CHT is regulated acutely by peroxynitrite.
Pinthong M; Black SA; Ribeiro FM; Pholpramool C; Ferguson SS; Rylett RJ
Mol Pharmacol; 2008 Mar; 73(3):801-12. PubMed ID: 17971421
[TBL] [Abstract][Full Text] [Related]
37. Changed iron regulation in scrapie-infected neuroblastoma cells.
Fernaeus S; Hälldin J; Bedecs K; Land T
Brain Res Mol Brain Res; 2005 Feb; 133(2):266-73. PubMed ID: 15710243
[TBL] [Abstract][Full Text] [Related]
38. The dopamine transporter proteome.
Torres GE
J Neurochem; 2006 Apr; 97 Suppl 1():3-10. PubMed ID: 16635244
[TBL] [Abstract][Full Text] [Related]
39. Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching.
Adkins EM; Samuvel DJ; Fog JU; Eriksen J; Jayanthi LD; Vaegter CB; Ramamoorthy S; Gether U
Biochemistry; 2007 Sep; 46(37):10484-97. PubMed ID: 17711354
[TBL] [Abstract][Full Text] [Related]
40. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
